Lectenz Bio is developing novel products that employ our unique Lectenz® reagents and GlycoSense™ technology, to speed up and simplify the detection and discovery of disease biomarkers. These products enable targeting glycan biomarkers of clinical significance for investigation and leveraging them for advancing human health. Glycan-based biomarkers are particularly important for disease diagnosis and clinical treatment, yet their discovery and detection is challenging, due to the lack of glycan-specific reagents and tools. We are meeting this important need by developing innovative technologies in the glycosciences that will advance critical research and clinical applications. We are excited about helping to improve human health in this underexploited area. The company’s mission is to develop technologies that enable novel glycoscience applications, provide services that enhance glycan biomarker detection, and deliver tools that advance research and clinical applications.